根据慢性疾病风险的差异影响:对ChooseWell 365随机对照试验的二次分析
J Cheng1,2, D E Levy3,4, J L McCurley5
1Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA.
Preventive medicine reports
|May 3, 2024
概括
职场健康饮食干预措施的有效性因员工健康状况而异. 那些患有慢性疾病的人体验到更大的卡路里减少和更少的体重增加,这表明定制计划可能是有益的.
科学领域:
- 职业健康 职业健康 职业健康
- 行为科学 行为科学
- 公共卫生 公共卫生
背景情况:
- 工作场所健康促进计划的有效性可能有所不同.
- 员工的健康状况可能会影响计划的结果.
- 了解这种关联对于优化干预至关重要.
研究的目的:
- 为了确定工作场所健康饮食干预措施的效果是否因基线慢性疾病状况而异.
- 分析行为干预对医院员工饮食和体重的影响.
- 研究基于慢性疾病的治疗效果的异质性.
主要方法:
- 一项涉及美国医院员工的随机对照试验的二次分析.
- 一个为期12个月的行为干预包括个性化的反,同行比较和财务激励.
- 参与者按慢性疾病状况分类;收集了BMI和食堂销售数据.
主要成果:
- 与对照组相比,患有慢性疾病的员工的卡路里摄入量减少明显.
- 患有慢性疾病的干预参与者体验到体重稳定,而没有体重增加的参与者体验到体重稳定.
- 干预对体重和卡路里摄入量的影响根据慢性疾病状况有显著差异.
结论:
- 工作场所的健康饮食干预措施根据员工的慢性疾病状况产生了差异性影响.
- 患有先前存在的慢性疾病的员工在减少卡路里和控制体重方面从干预中获益更多.
- 雇主应该考虑量身定制健康促进计划,以针对高风险的员工,以获得更好的结果.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Study Designs in Epidemiology
215
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
215
Hazard Ratio
115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
115
Levels of Health Promotion and Illness Prevention
12.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.6K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Relative Risk
157
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
157
